Despite overall declines in premature CVD mortality in the US, targeted public health interventions are needed due to rising mortality in specific demographic subgroups and from hypertensive disease.
Signals need for vigilance on subgroup rises in premature CVD mortality; leaves open optimal interventions pending prospective data.
There have been substantial declines in premature CVD mortality in much of the US population. However, increases in CVD mortality before age 50 years among American Indian/Alaska Native individuals, flattening rates in white people, and overall increases in deaths from hypertensive disease suggest that targeted public health interventions are needed to prevent these premature deaths.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: